Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05919147 · ClinicalTrials.gov registry record · Phase 2

The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia

A Phase 2 study of Lung Cancer, sponsored by Pennington Biomedical Research Center.

Active
Registry status
Phase 2
Development phase
24
Enrollment target
1
Study location

NCT05919147 is a Phase 2 study of Lung Cancer that is active but no longer recruiting, run by Pennington Biomedical Research Center. The registered enrollment target is 24 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05919147, a Phase 2 study of Lung Cancer, is active but no longer recruiting, sponsored by Pennington Biomedical Research Center.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is evaluate the effect of pioglitazone compared with placebo on skeletal muscle insulin sensitivity in subjects with cancer and cachexia.

Conditions Studied

Lung Cancer

Interventions

  • DRUG Placebo
  • DRUG Pioglitazone 45 mg

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2024-01-03
Est. Completion 2026-06-30
Phase Phase 2

Sponsor

Pennington Biomedical Research Center

258 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05919147

The ClinicalTrials.gov registry entry for NCT05919147 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (97% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05919147 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT05919147 about?

NCT05919147 is a clinical study titled "The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia". The goal of this clinical trial is evaluate the effect of pioglitazone compared with placebo on skeletal muscle insulin sensitivity in subjects with cancer and cachexia.

What is the current status of trial NCT05919147?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2024-01-03. Estimated completion is 2026-06-30.

What conditions does trial NCT05919147 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT05919147?

The interventions under investigation include: Placebo (DRUG), Pioglitazone 45 mg (DRUG).

Who is sponsoring clinical trial NCT05919147?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05919147 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Cancer

All registered trials for this condition

Louisiana

All trials with a study site in Louisiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.